2015 Fullbright Thought Leader Talk
Fulbright Taiwan is pleased to invite you to take part in the Thought Leader Talk on Wednesday, December 9, 2015. at the 3rd floor of our office. Snack will be served throughout this presentation. Regarding the lectures’ information, please see the following detail:
Date: Wednesday, December 9, 2015.
Venue: Foundation for Scholarly Exchange
Address: 3F, 45 Yanping S. Rd. Taipei. (台北市中正區延平南路45號3樓)
Speaker: Dr. Jeffrey Hou
Presentation Summary: Urban commoning has become a worldwide phenomenon from Europe to Asia. What characterizes the emerging cases in Taipei and Hong Kong? How are they distinct or similar to cases elsewhere?
Biography: Jeffrey Hou is Professor and Chair of Landscape Architecture at the University of Washington. His work focuses on community design, public space and democracy, and cross-cultural placemaking. He is the editor of Insurgent Public Space: Guerrilla Urbanism and the Remaking of Contemporary Cities, which received the 2012 Places Book Award.
Speaker: Dr. James Winkler
Presentation Summary: Currently, our ability to understand how microbes tolerate different environmental conditions, antibiotic treatments, and other insults is limited by the lack of a centralized resource containing genetic and gene expression data. This presentation will detail the creation of a tolerance-focused database (the “Resistome”) and present preliminary analysis of trait interactions.
Biography: Originally from Houston, Texas (USA), I completed both a bachelors and PhD in chemical engineering at universities in Texas. I subsequently moved to Colorado to conduct research in the Ryan Gill research group at University of Colorado-Boulder in order to better understand how we are currently engineering bacteria to produce fuels, chemicals, and pharmaceuticals needed for a renewable economy. As a Fulbright scholar, I am extending this research to understand how microbes and other organisms tolerate different types of chemical treatments, including antibiotics. The ultimate goal of my research is to design novel, evolution-resistant methods for combining antibiotics and engineering tolerance phenotypes into industrial biocatalysts.
Your participation will enrich the program by enhancing the diversity of perspectives and content. Please reply by December 4, 2015 to confirm your attendance at email: email@example.com. Thank you!
We are looking forward to seeing you at the presentation.